Cannabivarin (CBV) is a chemical compound that is the second most occurring and abundant of the cannabinoids in Cannabis sativa. Referred to as a non-psychoactive cannabinoid, the CBV does not have the euphoric effects that have been typically associated with the use of marijuana. In fact, the CBV is an oxidized product of tetrahydrocannabivarin, also known as THCV. A drug test upon the usage of CBV will detect the use of THC, though CBV might be more prevalent than THC.
Preliminary research suggests that CBV apparently has an effect on the endocannabinoid system. A possible chemopreventive effect on colon cancer is also being studied. CBV can be potentially used in the treatment of psychiatric and mood disorders, brain tumors, neuropathic pain, and multiple sclerosis. It is also believed that Cannabivarin has a positive impact on sexuality such as increased sexual desire.
Appetite control and regulation of body metabolism and weight are some other potential benefits of taking CBV. Research also suggests that this marijuana compound can have a positive impact on the sleep-wake cycle and treat specific sleeping disorders. Furthermore, certain studies haven’t denied the possibility of phytocannabinoids in reducing nausea and vomiting associated with chemotherapy treatment.